Canada Pension Plan Investment Board
APLS

Canada Pension Plan Investment Board’s Apellis Pharmaceuticals APLS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,600
Closed -$789K – 1710
2026
Q1 		$789K Sell
19,600
-202,600
-91% -$4.37M ﹤0.01% 1075
2025
Q4 		$5.58M Buy
222,200
+5,200
+2% +$122K ﹤0.01% 758
2025
Q3 		$4.91M Sell
217,000
-119,800
-36% -$2.79M ﹤0.01% 761
2025
Q2 		$5.83M Sell
336,800
-711,900
-68% -$13.2M 0.01% 683
2025
Q1 		$22.9M Buy
1,048,700
+1,013,500
+2,879% +$28M 0.02% 431
2024
Q4 		$1.12M Buy
+35,200
New +$1.06M ﹤0.01% 996
2024
Q1 		– Sell
-49,900
Closed -$2.99M – 1176
2023
Q4 		$2.99M Sell
49,900
-32,400
-39% -$1.64M ﹤0.01% 773
2023
Q3 		$3.13M Hold
82,300
– – ﹤0.01% 689
2023
Q2 		$7.5M Hold
82,300
– – 0.01% 509
2023
Q1 		$5.43M Hold
82,300
– – 0.01% 564
2022
Q4 		$4.26M Hold
82,300
– – 0.01% 557
2022
Q3 		$5.62M Sell
82,300
-6,900
-8% -$408K 0.01% 510
2022
Q2 		$4.03M Buy
+89,200
New +$4.07M 0.01% 566

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Canada Pension Plan Investment Board's APLS Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 19,600 shares — an estimated $789K sold.

Canada Pension Plan Investment Board first reported a position in APLS in Q2 2022 and held it in 13 quarters. The position peaked at $22.9M in Q1 2025. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 19,600 Apellis Pharmaceuticals shares in Q2 2026, an estimated $789K.
  • Canada Pension Plan Investment Board first reported a position in Apellis Pharmaceuticals in Q2 2022 and held it in 13 quarters.
  • Canada Pension Plan Investment Board's Apellis Pharmaceuticals position peaked at $22.9M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.